Lund, Sweden

Immunovia Ab

USPTO Granted Patents = 7

% Expired Patents = 14.3



Trademarks = 1

Forward Citations = 2

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Carl Arne Krister Borrebaeck (6 out of 13 patents)

silverMedal Lars Bertil Christer Wingren (3 out of 3 patents)

bronzeMedal Christer Lars Bertil Wingren (2 out of 2 patents)

4.  Anders Carlsson (1 out of 17 patents)

5.  Payam Delfani (1 out of 1 patent)

6.  Linda Dexlin Mellby (1 out of 1 patent)

7.  Björn Elleby (1 out of 1 patent)

8.  Sara Ek (1 out of 1 patent)

9.  Anna Rising (15 patents)

10.  My Hedhammar (17 patents)

11.  Per-Åke Nygren (2 patents)

12.  Jan H Johansson (90 patents)

13.  Sara Charlotte Andersson Ek (0 patent)

14.  Donal John Brennan (0 patent)

15.  Fredrik Nilsson (0 patent)


7 patents:

Company Overview
Immunovia AB is a Swedish biotech company focused on developing innovative diagnostic solutions for early detection and monitoring of complex diseases. Their flagship product, IMMray™ PanCan-d, is a blood test designed for early detection of pancreatic cancer, one of the deadliest forms of cancer. Immunovia's cutting-edge technology combines protein biomarker analysis with machine learning algorithms to provide highly accurate and reliable results. The company is dedicated to improving early detection rates and outcomes for patients with high-risk diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#60 in Lund

#812 in Sweden

Lund, SE
Lund, Sweden
Forward Citations = 2

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Immunovia Ab. Retrieved from https://idiyas.com/company/immunovia-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…